Boehringer Ingelheim Giotrif

Product Details

Descriptions

For the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have activating epidermal growth factor receptor (EGFR) mutations. For the treatment of patients with locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum based chemotherapy.

Get Reviews Widget

Leave a review

You may also like...